Assessment of asymmetric dimethyl arginine, cardiac troponin I, thyroxine, cholesterol, and triglyceride levels in obese dogs and dogs with normal body condition

The aim of this study was to assess serum asymmetric dimethyl arginine (ADMA), cardiac troponin I (cTnI), thyroxine (T4),cholesterol and triglyceride (TG) levels in dogs with normal body condition and obese dogs. A total of 40 dogs (n = 40) were includedin the study and dogs were divided into two groups; 20 dogs with normal body condition and 20 obese dogs. The dogs were groupedaccording to the five-point body-condition scoring (BCS) system. Serum ADMA, cTnI, T4, cholesterol, and TG levels were measuredin addition to routine biochemical parameters. Serum ADMA, cTnI, TG, and cholesterol levels were statistically significant betweenthe two groups (P < 0.001, P < 0.001, P = 0.027, P = 0.006, respectively). There was a positive correlation between the serum cholesterollevels and both TG and cTnI levels among obese dogs. It is thought that the findings of this study may help future studies in determiningnovel biomarkers for obesity in dogs.

PDF

___

1. Hamper B. Current topics in canine and feline obesity. Veterinary Clinics of North America Small Animal Practice 2016; 46 (5): 785-795. doi: 10.1016/j.cvsm.2016.04.003
2. Chandler M, Cunningham S, Lund EM, Khanna C, Naramore R et al. Obesity and associated comorbidities in people and companion animals: A one health perspective. Journal of Comparative Pathology 2017; 156 (4): 296-309. doi: 10.1016/j. jcpa.2017.03.006
3. Kirk CA. Preventing obesity in dogs and cats. In: Proceedings of the World Small Animal Veterinary Association World Congress; Jeju, Korea; 2011. pp. 11-14.
4. Laflamme DP. Companion Animals Symposium: Obesity in dogs and cats: What is wrong with being fat? Journal of Animal Science 2012; 90 (5): 1653-1662. doi: :10.2527/jas2011-4571
5. Bray GA. Classification and evaluation of the overweight patient. In: Bray G, Bouchard C, editors. Handbook of Obesity. 2nd ed. New York, NY, USA: Marcel Dekker Inc.; 2003. pp. 631-654.
6. Sanderson S. Obesity: health & mobility risks. In: Proceeding of the 83rd Annual Western Veterinary Conference; Las Vegas, NV, USA; 2011. pp. 1-8.
7. Montoya-Alonso JA. Canine obesity. In: Proceedings of the Southern European Veterinary Conference & Congreso Nacional AVEPA; Barcelona, Spain; 2008. pp. 9-13.
8. Flanagan J, Bissot T, Hours MA, Moreno B, FeugierA et al. Success of a weight loss plan for overweight dogs: the results of an international weight loss study. PLoS ONE 2017; 12 (9): e0184199. doi: 10.1371/journal.pone.0184199
9. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. International Journal of Obesity and Related Metabolic Disorders 2002; 26 (6): 754-764. doi: 10.1038/sj.ijo.0801995
10. Buğdaycı G, Serin E. Asymmetrical dimethylarginine (ADMA). Düzce Tıp Fakültesi Dergisi 2005; 2: 36-41 (article in Turkish with an English abstract).
11. Aydın M, Erdoğmuş F, Armutçu F, Yiğitoğlu MR. Metabolism of asymmetric dimethyl arginine (ADMA). International Journal of Basic and Clinical Medicine 2013; 1 (1): 61-66 (article in Turkish with an English abstract).
12. Krzyzanowska K, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. The Journal of Clinical Endocrinology & Metabolism 2004; 89 (12): 6277-6281. doi: 10.1210/jc.2004-0672
13. Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. Journal of Veterinary Internal Medicine 2001; 15 (15): 501-503. doi: 10.1111/j.1939-1676.2001.tb01582.x
14. Spratt DP, Mellanby RJ, Drury N, Archer J. Cardiac troponin I: evaluation of a biomarker for the diagnosis of heart disease in the dog. Journal of Small Animal Practice 2005; 46 (3): 139-145. doi: 10.1111/j.1748-5827.2005.tb00304.x
15. O’Brien1 PJ, Smith DEC, Knechtel TJ, Marchak MA, Pruimboom-Brees I et al. Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Laboratory Animals 2006; 40 (2): 153-171. doi: 10.1258/002367706776319042
16. Özkanlar S, Akçay F. Cardiac markers used in cats and dogs. Türkiye Klinikleri Journal Veterinary Science 2014; 5 (1): 35- 40 (article in Turkish with an English abstract).
17. Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. Journal of Veterinary Internal Medicine 2002; 16 (1): 63-68. doi: 10.1111/j.1939-1676.2002.tb01607.x
18. Schober KE, Cornand C, Kirbach B; Aupperle H, Oechtering G. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. Journal of American Veterinary Medical Association 2002; 221 (3): 381- 388. doi: 10.2460/javma.2002.221.381
19. Karagül H, Altıntaş A, Fidancı UR, Sel T. Tiroid fonksiyonu. In: Karagül H, Altıntaş A, Fidancı UR, Sel T, editors. Klinik Biyokimya. 1st ed. Ankara, Türkiye: Medisan Yayın Serisi: 45; 2000. pp. 251-220 (in Turkish).
20. Martin LJ, Siliart B, Dumon HJ, Nguyen PG. Hormonal disturbances associated with obesity in dogs. Journal of Animal Physiology and Animal Nutrition (Berlin) 2006; 90 (9- 10): 355-360. doi: 10.1111/j.1439-0396.2005.00589.x
21. Longhi S, Radetti G. Thyroid function and obesity. Journal of Clinical Research in Pediatric Endocrinology 2013; 5 (1): 40- 44. doi: 10.4274/Jcrpe.856
22. De Morco V, Noronha KSM, Casado TC, Nakandakare ER, Florio JC et al. Therapy of canine hyperlipidemia with bezafibrate. Journal of Veterinary Internal Medicine 2017; 31 (3): 717-722. doi: 10.1111/jvim.14701
23. Xenoulis PG, Steiner JM. Lipid metabolism and hyperlipidemia in dogs. The Veterinary Journal 2010; 183 (1): 12-21.
24. Cohen DE. Balancing cholesterol synthesis and absorption in the gastrointestinal tract. Journal of Clinical Lipidology 2008; 2 (2): 1-3. doi: 10.1016/j.jacl.2008.01.004
25. Zoran DL. Obesity in dogs and cats: a metabolic and endocrine disorder. Veterinary Clinics North America Small Animal Practice 2010; 40 (2): 221-239.
26. José Lahm Cardoso M, Fagnani R, Zaghi Cavalcante C, de Souza Zanutto M, Júnior AZ et al. Blood pressure, serum glucose, cholesterol, and triglycerides in dogs with different body scores. Veterinary Medicine International 2016; Article ID 8675287: 1-7. doi: 10.1155/2016/8675283
27. Sikaris KA. The clinical biochemistry of obesity. The Clinical Biochemist Reviews 2004; 25 (3): 165-181.
28. Koçak H, Öner-İyidoğan Y, Gürdol F, Öner P, Esin D. Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women. Journal of Clinical Laboratory Analysis 2011; 25 (3): 174-178. doi: 10.1002/jcla.20452
29. Park HJ, Lee SE, Oh JH, Seo KW, Song KH. Leptin, adiponectin and serotonin levels in lean and obese dogs. BioMed Central Veterinary Research 2014; 10: 113. doi: 10.1186/1746-6148-10- 113
30. Piantedosi D, Di Loria A, Guccione J, De Rosa A, Fabbri S et al. Serum biochemistry profile, inflammatory cytokines, adipokines and cardiovascular findings in obese dogs. The Veterinary Journal J 2016; 216: 72-78. doi: 10.1016/j. tvjl.2016.07.002
31. Huang F, Del-Río-Navarro BE, Torres-Alcántara S, Pérez- Ontiveros JA, Ruiz-Bedolla E et al. Adipokines, asymmetrical dimethylarginine, and pulmonary function in adolescents with asthma and obesity. Journal of Asthma 2017; 54 (2): 153-161. doi: 10.1080/02770903.2016.1200611
32. Li T, Feng R, Zhao C, Wang Y, Wang J et al. Dimethylarginine dimethylaminohydrolase 1 protects against high-fat dietinduced hepatic steatosis and insulin resistance in mice. Antioxidants & Redox Signaling 2017; 26 (11): 598-609. doi: 10.1089/ars.2016.6742
33. Mermer M, Acar Tek N. Adipose tissue and it’s effect on energy metabolism. Süleyman Demirel Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2017; 8 (3): 40-46 (article in Turkish with an English abstract).
34. Fessler MB, Rose K, Zhang Y, Jaramillo R, Zeldin DC. Relationship between serum cholesterol and indices of erytrocytes and platelets in the US population. Journal of Lipid Research 2013; 54 (11): 3177-3188. doi: 10.1194/jlr.P037614.
35. Xenoulis PG, Steiner JM. Canine hyperlipidaemia. Journal of Small Animal Practice 2015; 56 (10): 595-605. doi: 10.1111/ jsap.12396
36. Tanrıverdi B, Savaş Tetik Ş: Aterosklerozun patofizyolojisi ve risk faktörleri. Marmara Pharmaceutical Journal 2017; 21: 1-9 (in Turkish). doi: 10.12991/marupj.259875
37. Karam I, Yang YJ, Li JY. Hyperlipidemia background and progress. SM Atherosclerosis Journal 2017; 1 (1): 1003.
38. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesityassociated hypertension: new insights into mechanisms. Hypertension 2005; 45 (1): 9-14. doi: 10.1161/01. HYP.0000151325.83008.b4
39. Armstrong PJ, Lusby AL. Clinical importance of canine and feline obesity. In: Towell TL, editor. Practical Weight Management in Dogs and Cats. 1st ed. Sussex, UK: Jonh Wiley and Sons Inc.; 2011. pp. 3-23.
40. Tropf M, Nelson OL, Lee P. Cardiac function and metabolic parameters in obese dogs. In: Proceedings of American College of Veterinary Internal Medicine Forum; Denver, CO, USA; 2016. pp. 1424.
41. Yen JT, Pond WG. Plasma thyroid hormones, growth and carcass measurements of genetically obese and lean pigs as influenced by thyroprotein supplementation. Journal of Animal Science 1985; 61(3): 566-572. doi:10.2527/jas1985.613566x